|
|
News Breaks
|
February 9, 2012
|
| 18:22 EDT |  | RMTI |
| theflyonthewall.com: | Rockwell Medical 1.845M share registered direct offering priced at $9.50 | | Rockwell Medical Technologies announced that it has priced a firm commitment underwritten registered direct offering of 1.845M common shares at $9.50 per share for an aggregate offering amount of approximately $17.5M. Stifel Nicolaus Weisel is acting as sole book-running manager, Canaccord Genuity is acting as co-lead manager, and Rodman & Renshaw, LLC and Summer Street Research Partners are acting as co-managers. The offering is expected to close on February 15, subject to satisfaction of customary closing conditions. :theflyonthewall.com |
|
|
News For RMTI From The Last 14 Days Check below for free stories on RMTI the last two weeks.
There are 2 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing. |
|
May 21, 2012
|
| 08:41 EDT |  | RMTI |
| theflyonthewall.com: | Rockwell Medical may benefit from competitor's troubles, says Rodman & Renshaw |
 Subscribe for More Information :theflyonthewall.com |
| | 07:40 EDT |  | RMTI |
| theflyonthewall.com: | Rockwell Medical gets European patent issuance for proprietary SFP formulation | | Rockwell Medical announced that it has received notice from the European Patent Office that it has obtained patent issuance on its proprietary GMP formulation for Soluble Ferric Pyrophosphate, or SFP, the company's lead investigational drug that provides iron replacement to hemodialysis patients with chronic kidney disease, or CKD. :theflyonthewall.com |
|
|
|
|
|
